Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Recruiting Observational

European Real-World Registry for Use of the Ion Endoluminal System

NCT06923774 · tracked via the Priya Life Science France tracker
Phase
Observational
Started
2025-09-09
Last updated
2026-10-09

Condition(s) studied

Pulmonary NoduleLung Cancer

Investigational drug(s) / intervention(s)

Ion endoluminal system

Ion endoluminal system: Lung nodule biopsy and/or localization procedure using the Ion endoluminal system per sites' standard of care

Study summary

The objective of this study is to collect collect real-world data for the Ion endoluminal system.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Patient is aged 18 years or older at time of consent. * Patient is planned to undergo a lung lesion biopsy(s) and/or localization procedure(s) utilizing the Ion endoluminal system. * Patient is willing and able to give written informed consent for clinical study participation. Exclusion Criteria: * Patient is participating in an interventional research study or research study with investigational agents with an unknown safety profile that would interfere with participation in this study or study results. * Female patient that is pregnant or breast feeding as determined by standard site practices. * Patient is legally incapacitated or in a legal/court ordered institution or is part of a known vulnerable population, including but not limited to dependency on the sponsor, hospital or study doctor. * Patient is not willing to comply with post-procedure study participation requirements. * Investigator, in their professional opinion, has decided that it is in the patient's best interest to not participate in the clinical study.

Primary outcome measure(s)

  • Diagnostic Yield — Intra-procedure through 24 month post-procedure
    Diagnostic Yield defined as the sum of true positives and true negatives divided by the total number of nodules biopsied. Primary outcome analyses will exclude subjects that are enrolled for localization procedure only.

Trial sites (9)

FacilityCityRegionStatus
CHU de Brest, Hôpital de La Cavale Blanche Brest France Not Yet Recruiting
Hôpital Marie Lannelongue Le Plessis-Robinson France Recruiting
CHU de Rouen Rouen France Not Yet Recruiting
Helios Klinikum Emil von Behring Berlin Germany Recruiting
DGD Lungenklining Hemer Hemer Germany Recruiting
Helios Dr. Horst Schmidt Kliniken Wiesbaden Germany Recruiting
Universitätsspital Zürich Zurich Switzerland Recruiting
University College London Hospitals NHS Foundation Trust London United Kingdom Recruiting
Wythenshawe Hospital, Manchester University NHS Foundation Trust Manchester United Kingdom Recruiting

More Intuitive Surgical trials in France

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06923774 on ClinicalTrials.gov ↗ ← All trials in France